Top Story

with Kelly Cawcutt, MD, MS

with Kelly Cawcutt, MD, MS
Infectious Disease News, April 2019

Seqirus makes plans to transition to cell-based flu vaccine

April 23, 2019
Seqirus announced plans manufacture its influenza vaccine for the 2019-2020 season using an exclusively cell-based production process for the first time. Russell
Meeting News

‘Significant’ proportion of health care workers, patients shed flu virus before symptoms appear

April 20, 2019
Researchers tracking influenza transmission at a tertiary care hospital in Switzerland found that a “significant” proportion of patients and health care…
Meeting News

Insurance type impacts how adults are vaccinated

April 18, 2019
BALTIMORE — The type of insurance coverage that an adult has impacts how they are vaccinated, according to research presented at the National Foundation for…
More Headlines »

Implications of Emerging Antiviral Agents for Influenza: Assessing the Evidence

This activity is supported by an educational grant from Genentech, Inc.

The administration of influenza vaccines has remained the most effective way to prevent seasonal influenza. However…
More »
Meeting News

Opioid epidemic the ‘public health issue of our time,’ CDC’s Redfield says

April 4, 2019
BALTIMORE — CDC Director Robert R. Redfield, MD, recounted an incident he witnessed riding the train to work 1…
More »
Meeting News

VIDEO: Vaccine significantly reduces risk for influenza-related death in children

June 5, 2017
More »